hPSC dual-SMAD neural induction media

Stem-cell differentiationLiterature recipe

Noggin and SB431542 neural induction in KSR medium followed by staged N2 medium replacement.

Applicable scenario

Adherent neural conversion of human ESCs or iPSCs using Chambers et al.'s dual-SMAD inhibition method. Use KSR with both inhibitors initially, withdraw SB431542 on day 5, then increase N2 medium while maintaining Noggin.

Import to Workspace
QR code to import hPSC dual-SMAD neural induction media into Listen Step Workspace

Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.

Import to the Android App instead · Download Recipe JSON

Formulation tables

Days 0–5 · dual-SMAD induction

ComponentFinal concentrationTiming
KSR mediumBasal mediumDays 0–5
Noggin500 ng/mLDays 0–5
SB43154210 µMDays 0–5; withdraw on day 5

Day 5 · 25% N2 transition

ComponentProportion / concentrationTiming
N2 medium25%Day 5
KSR medium75%Day 5
Noggin500 ng/mLMaintain
SB431542NoneWithdrawn

Day 7 · 50% N2 transition

ComponentProportion / concentrationTiming
N2 medium50%Day 7
KSR medium50%Day 7
Noggin500 ng/mLMaintain
SB431542NoneWithdrawn

Day 9 · 75% N2 transition

ComponentProportion / concentrationTiming
N2 medium75%Day 9
KSR medium25%Day 9
Noggin500 ng/mLMaintain
SB431542NoneWithdrawn

Source values and calculations

Literature source

Chambers SM et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnology 27, 275–280 (2009).

Source locator: Materials and Methods, Neural Induction

Read the original source · DOI: 10.1038/nbt.1529

Related source: Corrigendum: Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnology 27, 485 (2009).

Source locator: Correction of the SB431542 unit from nM to µM

Read the related source · DOI: 10.1038/nbt0509-485a

Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.